Literature DB >> 35913652

Identifying the risk of opioid misuse in a chronic pain population: the utility of the MMPI-2-RF personality psychopathology five (PSY-5-RF) and higher-order scales.

Madeline J Giblin1, Millie Cordaro1, Kelly Haskard-Zolnierek1, Krista Jordan2, Catherine Bitney1, Krista Howard3.   

Abstract

Prescription-related opioid misuse, especially in chronic pain populations, is an ongoing problem and is related to increased mortality. The purpose of this study was to assess the utility of two restructured scales of the MMPI-2-RF: the Personality Psychopathology Five (PSY-5-RF) and the Higher-Order Scales to determine which of their subscales may be beneficial for identifying the risk of opioid misuse in a chronic pain population. A sample of 136 patients with chronic disabling occupational musculoskeletal disorders completed the MMPI-2-RF and the Current Opioid Misuse Measure (COMM) upon admission to a functional restoration program. The PSY-5-RF and H-O subscales were correlated with the baseline COMM scores. Correlation analyses, ROC curve analyses, and multiple binary logistic regression models were developed to determine which subscales were most associated with elevated COMM scores. The results of the regression analyses suggest that Scale elevations on two of the PSY-5-RF Scales and two Higher-Order Scales of the MMPI-2-RF demonstrated significant associations with elevated COMM scores, thus exhibiting the utility of these subscales in identifying the risk of opioid misuse among chronic pain patients. These findings are clinically meaningful in underscoring the importance of identifying specific personality traits as potential predictors of opioid misuse, and identifying those at risk through careful screening. Clinical implications based on each of the PSY-5-RF and H-O scales significantly associated with elevated COMM scores are discussed.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Chronic pain; MMPI-2-RF; Opioid abuse; Opioid misuse

Year:  2022        PMID: 35913652     DOI: 10.1007/s10865-022-00347-w

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  29 in total

1.  Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts.

Authors:  Lisham Ashrafioun; Todd M Bishop; Kenneth R Conner; Wilfred R Pigeon
Journal:  J Psychiatr Res       Date:  2017-03-19       Impact factor: 4.791

Review 2.  Psychological risk factors for poor outcome of spine surgery and spinal cord stimulator implant: a review of the literature and their assessment with the MMPI-2-RF.

Authors:  Andrew R Block; Yossef S Ben-Porath; Ryan J Marek
Journal:  Clin Neuropsychol       Date:  2012-09-21       Impact factor: 3.535

3.  Measurement of DSM-5 section II personality disorder constructs using the MMPI-2-RF in clinical and forensic samples.

Authors:  Jaime L Anderson; Martin Sellbom; Carly Pymont; Wineke Smid; Hilde De Saeger; Jan H Kamphuis
Journal:  Psychol Assess       Date:  2015-03-23

4.  Catastrophizing, depression and pain-related disability.

Authors:  Bruce A Arnow; Christine M Blasey; Michael J Constantino; Rebecca Robinson; Enid Hunkeler; Janelle Lee; Bruce Fireman; Anna Khaylis; Lauren Feiner; Chris Hayward
Journal:  Gen Hosp Psychiatry       Date:  2011-02-21       Impact factor: 3.238

5.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

6.  MMPI profiles of opiate addicts: predicting response to treatment.

Authors:  M A Belding; M Y Iguchi; A R Morral; S D Husband
Journal:  J Pers Assess       Date:  1998-04

7.  Temperament and character personality profiles and personality disorders in chronic pain patients.

Authors:  Rupert Conrad; Guntram Schilling; Christiane Bausch; Joachim Nadstawek; Hans Christian Wartenberg; Ingo Wegener; Franziska Geiser; Katrin Imbierowicz; Reinhard Liedtke
Journal:  Pain       Date:  2007-10-25       Impact factor: 6.961

8.  Evaluation of How Depression and Anxiety Mediate the Relationship Between Pain Catastrophizing and Prescription Opioid Misuse in a Chronic Pain Population.

Authors:  Javier Arteta; Briana Cobos; Yueqin Hu; Krista Jordan; Krista Howard
Journal:  Pain Med       Date:  2016-02       Impact factor: 3.750

9.  Classification accuracy of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2)-Restructured form validity scales in detecting malingered pain-related disability.

Authors:  Kevin J Bianchini; Luis E Aguerrevere; Kelly L Curtis; Tresa M Roebuck-Spencer; F Charles Frey; Kevin W Greve; Matthew Calamia
Journal:  Psychol Assess       Date:  2017-10-26

10.  Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016.

Authors:  James Dahlhamer; Jacqueline Lucas; Carla Zelaya; Richard Nahin; Sean Mackey; Lynn DeBar; Robert Kerns; Michael Von Korff; Linda Porter; Charles Helmick
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-09-14       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.